ArticleCureus2024

Dilated Cardiomyopathy, De Novo Heart Failure, and Cardiogenic Shock With End-Organ Failure in a Patient With No Cardiac History Following a Trial of Amitriptyline.

Zachary S Kauffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.